L-Base
Seoul
About L-Base
L-Base specializies in the development of anti-cancer drugs and autophagy inhibitor drugs for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2018)
- Website: l-base.com
- Phone: + 82 02 907 3356
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/l-base-207502 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.